Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Therapeutics entities : Iterum therapeutics plc save search
Iterum Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-03-28 (Crawled : 11:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 1.89%
H: 3.09%
C: -4.94%
year therapeutics financial results
Iterum Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results on March 28, 2024
Published: 2024-03-21 (Crawled : 21:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: -0.63%
H: 5.1%
C: 1.91%
report year therapeutics financial results
Iterum Therapeutics to Participate in H.C. Wainwright Virtual @Home Fireside Chat
Published: 2024-03-15 (Crawled : 12:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 0.0%
H: 5.82%
C: 0.69%
therapeutics
Iterum Therapeutics Provides Business Update
Published: 2024-03-06 (Crawled : 13:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 9.09%
H: 13.77%
C: 7.97%
business update therapeutics
Iterum Therapeutics Announces Positive Topline Results from its Phase 3 REASSURE Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
Published: 2024-01-30 (Crawled : 12:00) - prnewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 28.49%
H: 1.74%
C: -31.3%
positive topline sulopenem infections trial therapeutics results
Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
Published: 2023-12-04 (Crawled : 13:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: -1.89%
H: 5.77%
C: 1.44%
nasdaq therapeutics
Iterum Therapeutics Reports Third Quarter 2023 Financial Results
Published: 2023-11-14 (Crawled : 12:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: -5.18%
H: 8.22%
C: 8.22%
therapeutics financial results
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2023 Financial Results on November 14, 2023
Published: 2023-11-07 (Crawled : 14:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: -3.9%
H: 3.04%
C: 2.7%
report business update therapeutics financial results
Iterum Therapeutics Announces Completion of Enrollment in its REASSURE Phase 3 Clinical Trial of Oral Sulopenem in Uncomplicated Urinary Tract Infections
Published: 2023-10-24 (Crawled : 12:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 4.37%
H: 2.4%
C: 2.4%
sulopenem infections trial therapeutics
Iterum Therapeutics to Present Data at IDWeek 2023
Published: 2023-10-12 (Crawled : 13:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: -3.42%
H: 24.82%
C: 7.8%
therapeutics
Iterum Therapeutics Reports Second Quarter 2023 Financial Results
Published: 2023-08-11 (Crawled : 11:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 6.93%
H: 1.85%
C: 0.93%
therapeutics financial results
Iterum Therapeutics to Provide Business Update and Report Second Quarter 2023 Financial Results on August 11, 2023
Published: 2023-08-04 (Crawled : 21:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
| Email alert
Add to watchlist
report business update therapeutics financial results
Iterum Therapeutics to Present Data at ASM Microbe 2023
Published: 2023-06-12 (Crawled : 23:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 5.41%
H: 0.0%
C: -1.71%
therapeutics
Iterum Therapeutics Reports First Quarter 2023 Financial Results
Published: 2023-05-12 (Crawled : 11:00) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 2.65%
H: 3.45%
C: -1.72%
therapeutics financial results
Iterum Therapeutics Presented Data at the 32nd European Congress of Clinical Microbiology and Infectious Diseases
Published: 2022-04-25 (Crawled : 14:20) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 0.11%
H: 1.06%
C: -6.79%
therapeutics
Iterum Therapeutics Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Published: 2022-06-14 (Crawled : 14:20) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 6.15%
H: 7.48%
C: -3.27%
nasdaq grant therapeutics
Iterum Therapeutics Reports Second Quarter 2022 Financial Results
Published: 2022-08-12 (Crawled : 14:20) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 0.8%
H: 4.17%
C: 3.21%
therapeutics financial results
Iterum Therapeutics Regains Compliance with Nasdaq Bid Price Rule
Published: 2022-09-01 (Crawled : 14:20) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 1.15%
H: 0.38%
C: -7.58%
nasdaq therapeutics
Iterum Therapeutics to Provide Business Update and Report Third Quarter 2022 Financial Results on November 10, 2022
Published: 2022-11-03 (Crawled : 14:20) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: 0.0%
H: 0.6%
C: -2.41%
report business update therapeutics financial results
Iterum Therapeutics Reports Third Quarter 2022 Financial Results
Published: 2022-11-10 (Crawled : 14:20) - globenewswire.com
ITRM | $1.45 -0.69% -0.69% 57K
|
Health Technology
|
| O: -2.46%
H: 7.19%
C: 2.88%
therapeutics financial results
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.